Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A ratiometric fluorescent probe consisting of Zn-MOF and calcium ion for sensitive and visual detection of doxycycline.

Analytica chimica acta·2026
Same author

Progestin-primed ovarian stimulation protocol in patients undergoing assisted reproductive technology.

Frontiers in reproductive health·2026
Same author

Efficacy of 0.5% Voriconazole Subpalpebral Lavage as Adjunctive Therapy: A Multicenter Prospective Study in Fungal Keratitis Management.

Ocular immunology and inflammation·2026
Same author

Downward comparisons enhance carbon credit policy sustainability: Lab evidence.

iScience·2025
Same author

The primary hospitals should take gait speed as a routine test for elderly patients.

Scientific reports·2025
Same author

Evaluation of representativeness and sustainability of PCOS rat models induced by letrozole with or without high-fat diet.

Scientific reports·2025

Related Experiment Video

Updated: May 9, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Recent advances in multinuclear complexes as potential anticancer and DNA binding agents.

Kehua Wang, Enjun Gao1

  • 1School of Chemistry and Life Science, Anshan Normal University, Anshan, Liaoning 114007, P.R. China. khwang16@gmail.com.

Anti-Cancer Agents in Medicinal Chemistry
|July 23, 2013
PubMed
Summary

Researchers are exploring multinuclear platinum and ruthenium complexes as novel anticancer agents. These metal complexes show unique DNA binding properties, offering new strategies beyond traditional platinum drugs like cisplatin.

More Related Videos

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
10:05

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)

Published on: January 20, 2016

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
12:19

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks

Published on: November 10, 2016

Related Experiment Videos

Last Updated: May 9, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
10:05

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)

Published on: January 20, 2016

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
12:19

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks

Published on: November 10, 2016

Area of Science:

  • Medicinal Chemistry
  • Inorganic Chemistry
  • Cancer Research

Background:

  • Cisplatin is a widely used platinum-based chemotherapy drug.
  • There is a continuous need for novel anticancer agents with improved efficacy and reduced side effects.
  • Multinuclear metal complexes, particularly those involving platinum and ruthenium, are emerging as promising candidates.

Purpose of the Study:

  • To review recent advancements in multinuclear platinum and ruthenium complexes as anticancer agents.
  • To summarize the novel DNA binding interactions of these complexes.
  • To provide insights into the rational design of polynuclear anticancer drugs.

Main Methods:

  • Literature review of multinuclear platinum and ruthenium complexes.
  • Analysis of studies focusing on DNA binding properties.
  • Summary of reported anticancer activities and mechanisms.

Main Results:

  • Multinuclearity enhances chemotherapeutic activity, as demonstrated in complexes like BBR3464.
  • Ruthenium complexes are being explored as alternatives to platinum complexes.
  • Novel DNA binding modes include phosphate clamps, long-range cross-links, bisintercalation, interduplex cross-links, and DNA-protein cross-links.

Conclusions:

  • Multinuclear platinum and ruthenium complexes represent a promising frontier in anticancer drug development.
  • Understanding their diverse DNA binding mechanisms is crucial for designing next-generation metallodrugs.
  • These complexes offer potential advantages over existing therapies by engaging DNA in unique ways.